India's Dr Reddy's warns of wider semaglutide supply impact after profit miss - Reuters
India's Dr Reddy's warns of wider semaglutide supply impact after profit miss Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOSFAtelUyWWdRNy1NQnR1bVlja1ZYalVpc0plZjBNYnFtU1hhNVA4X29hc2dqYW5FUmZEVkMwZnh0MjRIVFEtaWRxOURpMXRwSHBpWTlWeHd5R0xOMnZselhlRm0tcHdodkJONk94RHVya3BjWHFFaE4xdk5YVHcyZTlRdWtOTlBtRjRZbm44ZHBVNDhTdER1SHVEbzFkM3IxaVp5OUMtYS1MV3JaeHRhQ2wxVjk0VWw2YjJCamZmdEg5RXVOUXc?oc=5" target="_blank">India's Dr Reddy's warns of wider semaglutide supply impact after profit miss</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui - Reuters
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui Reuters
September 29, 2026 at 04:47 AMRegeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com
September 30, 2026 at 10:30 PMMcCormick's price hikes spice up quarterly results despite sluggish demand - Reuters
McCormick's price hikes spice up quarterly results despite sluggish demand Reuters
October 1, 2026 at 06:37 PMFood giants in India call for reconsidering red colour of warning labels - Reuters
Food giants in India call for reconsidering red colour of warning labels Reuters
September 28, 2026 at 05:05 AMUS FDA extends review of Novo Nordisk's hemophilia drug over facility issues - Reuters
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues Reuters
October 2, 2026 at 09:52 PMLilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com
Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com
September 29, 2026 at 10:15 PM